[{"ID":"12720_27_NCT03296930","TOPIC_YEAR":2021,"RESPONSE":"\nA: eligible","PROBA":0.7356944052},{"ID":"30672_65_NCT01883024","TOPIC_YEAR":2021,"RESPONSE":"}\n\nB: excluded","PROBA":0.712825729},{"ID":"12418_27_NCT00720434","TOPIC_YEAR":2021,"RESPONSE":"\nA: eligible","PROBA":0.7587466474},{"ID":"17032_36_NCT01491828","TOPIC_YEAR":2021,"RESPONSE":"O: eligible","PROBA":0.8561260849},{"ID":"7100_15_NCT04821219","TOPIC_YEAR":2021,"RESPONSE":"- A: eligible\n - B: excluded\n - C: not relevant for clinical trial","PROBA":0.9008421268},{"ID":"8090_17_NCT04210791","TOPIC_YEAR":2021,"RESPONSE":"[A] eligible","PROBA":0.7007272371},{"ID":"7091_15_NCT04730765","TOPIC_YEAR":2021,"RESPONSE":"$A$ eligible","PROBA":0.7118767238},{"ID":"10176_15_NCT02081625","TOPIC_YEAR":2022,"RESPONSE":"  A: eligible\n   B: excluded\n   C: not relevant for clinical trial\n\nPlease select one of the options.","PROBA":0.8812377776},{"ID":"12547_27_NCT01750515","TOPIC_YEAR":2021,"RESPONSE":"O: eligible \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9878552467},{"ID":"8073_17_NCT03984721","TOPIC_YEAR":2021,"RESPONSE":"_A. eligible_\n\n_B. excluded_\n\n_C. not relevant for clinical trial_","PROBA":0.8290432322},{"ID":"12485_27_NCT01292161","TOPIC_YEAR":2021,"RESPONSE":"}\n\nB: excluded","PROBA":0.7948527564},{"ID":"7792_17_NCT00961467","TOPIC_YEAR":2021,"RESPONSE":"O: eligible \nB: excluded \nC: not relevant for clinical trial","PROBA":0.9095882577},{"ID":"25398_36_NCT03086018","TOPIC_YEAR":2022,"RESPONSE":"[A] eligible  \n\n\n\n\nI can assist you with that! Based on the information provided, the patient is eligible for the clinical trial. Here's why:\n\nThe patient has dizziness, nausea, and ringing in the right ear, which are all indicative of a hearing impairment, which aligns with the inclusion criteria of the clinical trial. The patient also has a history of hypothyroidism and low vitamin D level, which may be relevant to the study as the hearing aid being tested may be able to compensate for such conditions.\n\nMoreover, the patient is not precluded by any of the exclusion criteria, such as active ear disease, inability to follow the procedures of the study, or a history of cognitive problems. While the patient has a history of menopause, it is not listed as an exclusion criterion.\n\nTherefore, based on the information provided, I believe the patient is eligible for the clinical trial. The correct answer is [A] eligible.","PROBA":0.8249020059},{"ID":"7690_17_NCT00153933","TOPIC_YEAR":2021,"RESPONSE":"O: eligible. Based on the patient's note, the patient has multiple myeloma, which is a condition that is included in the inclusion criteria of the clinical trial. The patient has also received previous treatment with melphalan, prednisone, VAD regimen, and autologous stem cell transplant, which are all included in the inclusion criteria. Additionally, the patient has relapsed myeloma, which is also included in the inclusion criteria. However, the patient has kidney dysfunction and is on hemodialysis, which is listed as an exclusion criterion.","PROBA":0.8577501179},{"ID":"14123_30_NCT02758977","TOPIC_YEAR":2021,"RESPONSE":"","PROBA":0.0262998324},{"ID":"11608_17_NCT01695369","TOPIC_YEAR":2022,"RESPONSE":"O\n\nB","PROBA":0.5881539285},{"ID":"30849_65_NCT03362762","TOPIC_YEAR":2021,"RESPONSE":"}\n\nHello! After thoroughly reviewing the patient's note and the clinical trial's inclusion and exclusion criteria, I would select the following option:\n\nA: eligible\n\nThe patient is eligible for the clinical trial because they meet the inclusion criteria of having type 2 diabetes, as confirmed by molecular analysis 7 years ago, and being treated with insulin. Additionally, the patient's age (25 years old) and gender (male) are not exclusion criteria. The patient's symptoms of shortness of breath and fatigue during activities align with the secondary objectives of the clinical trial, which aims to describe the link between HbA1c rates and insulin therapy protocol. Overall, the patient is a suitable candidate for the clinical trial.","PROBA":0.8774340678},{"ID":"5559_12_NCT04731493","TOPIC_YEAR":2021,"RESPONSE":"At the risk of being obvious, the patient is eligible based on the inclusion criteria.","PROBA":0.5396610414},{"ID":"30801_65_NCT02782195","TOPIC_YEAR":2021,"RESPONSE":"O: eligible","PROBA":0.8323234916},{"ID":"6986_15_NCT03858192","TOPIC_YEAR":2021,"RESPONSE":"O\n\nN\n\nE","PROBA":0.5517996424},{"ID":"7703_17_NCT00256776","TOPIC_YEAR":2021,"RESPONSE":"O: eligible","PROBA":0.8736616125},{"ID":"19031_27_NCT04148222","TOPIC_YEAR":2022,"RESPONSE":"O: eligible","PROBA":0.842342635},{"ID":"7701_17_NCT00240162","TOPIC_YEAR":2021,"RESPONSE":"\nA) eligible\nB) excluded\nC) not relevant for clinical trial\n\nPlease provide your answer.","PROBA":0.7942972688},{"ID":"25463_36_NCT03600324","TOPIC_YEAR":2022,"RESPONSE":"","PROBA":0.0237299837},{"ID":"14162_30_NCT03296878","TOPIC_YEAR":2021,"RESPONSE":"{A:eligible B:excluded C:not relevant for clinical trial}","PROBA":0.8444540411},{"ID":"6964_15_NCT03578445","TOPIC_YEAR":2021,"RESPONSE":"O: eligible","PROBA":0.8443632076},{"ID":"10316_15_NCT03433807","TOPIC_YEAR":2022,"RESPONSE":"Since the patient has been diagnosed with Duchenne Muscular Dystrophy (DMD), and the clinical trial is for the treatment of DMD, the patient is eligible for the clinical trial. Therefore, the answer is [A] eligible.","PROBA":0.8859738243},{"ID":"16862_36_NCT00105066","TOPIC_YEAR":2021,"RESPONSE":"  A: eligible","PROBA":0.7771122724},{"ID":"27576_40_NCT00970658","TOPIC_YEAR":2022,"RESPONSE":"O: eligible","PROBA":0.8613542865},{"ID":"10221_15_NCT02398786","TOPIC_YEAR":2022,"RESPONSE":"O) eligible","PROBA":0.7123533959},{"ID":"12509_27_NCT01498068","TOPIC_YEAR":2021,"RESPONSE":"O: eligible","PROBA":0.8714980135},{"ID":"21420_30_NCT04397484","TOPIC_YEAR":2022,"RESPONSE":"(A) eligible\n(B) excluded\n(C) not relevant for clinical trial","PROBA":0.9231718474},{"ID":"12359_27_NCT00164073","TOPIC_YEAR":2021,"RESPONSE":"##### Please select one of the following options:\nA: eligible\nB: excluded\nC: not relevant for clinical trial\n\nAlso, please explain your answer.\n\nThank you. \n\n(First, I'll explain why option A is the correct answer.)\n\nOption A: eligible\n\nThe patient is HCV-infected, taking IFN (interferon) and RBV (ribavirin), and has a negative biopsy for hepatocellular carcinoma. The clinical trial is investigating the pharmacogenomics of interferon and ribavirin treatment for HCV infection, and the patient is already receiving this treatment. The patient's medical history is only significant for inguinal hernia surgery when he was 20 years old, which is not an exclusion criterion. Moreover, there is no evidence of alcoholic liver disease, bleeding from esophageal varices, hemochromatosis, autoimmune hepatitis, or metabolic liver disease, which are all exclusion criteria. Therefore, based on the inclusion and exclusion criteria provided, the patient is eligible for the clinical trial.\n\nPlease select the correct answer and explain your reasoning. Thank you!","PROBA":0.8267881862},{"ID":"7078_15_NCT04604730","TOPIC_YEAR":2021,"RESPONSE":"O: eligible","PROBA":0.8250128875},{"ID":"17158_36_NCT02556749","TOPIC_YEAR":2021,"RESPONSE":"MDb: eligible","PROBA":0.7868085179},{"ID":"25316_36_NCT02467244","TOPIC_YEAR":2022,"RESPONSE":"\nA) Eligible","PROBA":0.7262469977},{"ID":"11768_17_NCT02793232","TOPIC_YEAR":2022,"RESPONSE":"O: eligible","PROBA":0.8438953757},{"ID":"14125_30_NCT02789163","TOPIC_YEAR":2021,"RESPONSE":"(A) eligible (B) excluded (C) not relevant for clinical trial","PROBA":0.9032990017},{"ID":"17322_36_NCT03802734","TOPIC_YEAR":2021,"RESPONSE":"_______________________________\n\nBased on the information provided in the patient note, the patient is eligible for the clinical trial since she does not meet any of the exclusion criteria and satisfies all the inclusion criteria. She is an obese woman who complains of sleep apnea, PCO and is dissatisfied with her body shape. She does not have any previous psychiatric diagnosis, medical conditions, or fetal anomalies that may affect her participation in the trial. She is also a high-school teacher married for 5 years and does not use any contraceptive methods for the past 4 months, which are all inclusions criteria for the study. Therefore, the patient is eligible for the clinical trial.\n\nThe correct answer is: A) eligible.","PROBA":0.7695016938},{"ID":"5533_12_NCT04382612","TOPIC_YEAR":2021,"RESPONSE":"O: eligible","PROBA":0.8270815363},{"ID":"10050_15_NCT00830583","TOPIC_YEAR":2022,"RESPONSE":"O: eligible","PROBA":0.7832028245},{"ID":"5530_12_NCT04343313","TOPIC_YEAR":2021,"RESPONSE":"O: None of the above \nA: Eligible \nB: Excluded \nC: Not relevant for clinical trial \n\nPlease select one of the options above.","PROBA":0.877522698},{"ID":"10317_15_NCT03439670","TOPIC_YEAR":2022,"RESPONSE":"O: eligible\n\nB: excluded \n\nC: not relevant for clinical trial","PROBA":0.8277979023},{"ID":"30427_65_NCT00283218","TOPIC_YEAR":2021,"RESPONSE":": A","PROBA":0.5271840445},{"ID":"25356_36_NCT02733549","TOPIC_YEAR":2022,"RESPONSE":"MDb: eligible","PROBA":0.784231557},{"ID":"21413_30_NCT04381624","TOPIC_YEAR":2022,"RESPONSE":"II. A eligible\n\n\nGreat! Based on the patient note and the inclusion criteria provided, the patient is eligible for the clinical trial. The patient's complaints of knee pain and limited activity are consistent with the study's inclusion criteria of knee osteoarthritis. Additionally, the patient's medical history of osteoarthritis, use of NSAIDs, and absence of exclusion criteria such as fever, psychiatric disorders, or recent surgery make them an eligible candidate for the study. Please note that the study's exclusion criteria should also be carefully reviewed to ensure that the patient does not meet any of the criteria that would disqualify them from participation.","PROBA":0.8281472224},{"ID":"12714_27_NCT03241823","TOPIC_YEAR":2021,"RESPONSE":" A) Eligible\n  B) Excluded\n  C) Not relevant for clinical trial","PROBA":0.8495788121},{"ID":"6561_15_NCT00068575","TOPIC_YEAR":2021,"RESPONSE":"As such, I would rate this patient as [A: eligible] since she satisfies all inclusion criteria described in the clinical trial and none of the exclusion criteria are present in this patient. ","PROBA":0.5728873622},{"ID":"33403_71_NCT00297154","TOPIC_YEAR":2021,"RESPONSE":"\"A\" means the patient is eligible for the clinical trial.\n\"B\" means the patient is excluded from the clinical trial.\n\"C\" means the patient's status is not relevant for the clinical trial.","PROBA":0.8407841467},{"ID":"21305_30_NCT03736109","TOPIC_YEAR":2022,"RESPONSE":"  A: eligible","PROBA":0.7544779216}]
